Table 1.

Characteristics of IFX-treated patients and untreated healthy controls

	Patients	Untreated controls
Mean age	37 y	35 y
Gender distribution	60 % female	75 % female
Mean ADA level	51 µg/ml	<1.25 µg/ml

y years, ADA anti-drug antibody